Key Events This Week
17 Aug: Technical momentum shifts amid mixed market signals
18 Aug: Mojo Grade downgraded from Buy to Hold reflecting mixed fundamentals
20 Aug: Bullish momentum shift with technical upgrades and valuation changes
21 Aug: Week closes at Rs.276.25, up 8.08% vs Sensex decline

Viyash Scientific Ltd Sees Bullish Momentum Shift Amid Technical Upgrades
2026-08-20 08:00:47Viyash Scientific Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by a 6.03% surge in the stock price to ₹270.00 on 20 Aug 2026, reflecting renewed investor interest and positive technical signals across multiple timeframes.
Read full news article
Viyash Scientific Ltd Valuation Shifts Signal Changing Market Sentiment
2026-08-20 08:00:15Viyash Scientific Ltd has experienced a notable shift in its valuation parameters, prompting a reassessment of its price attractiveness within the Pharmaceuticals & Biotechnology sector. The company’s price-to-earnings (P/E) ratio has surged to 49.5, marking a transition from fair to expensive valuation territory, while its price-to-book value (P/BV) now stands at 4.08. This article analyses these changes in the context of historical trends, peer comparisons, and broader market performance to provide investors with a comprehensive view of Viyash Scientific’s current standing.
Read full news article
Viyash Scientific Ltd Downgraded to Hold Amid Mixed Financial and Technical Signals
2026-08-19 08:10:12Viyash Scientific Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 18 Aug 2026. This adjustment follows a comprehensive reassessment of the company’s quality, valuation, financial trends, and technical indicators, reflecting a more cautious stance despite solid long-term growth and recent positive quarterly results.
Read full news article
Viyash Scientific Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-08-17 08:00:33Viyash Scientific Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in daily price performance, the company’s longer-term technical indicators and fundamental mojo score suggest a cautiously optimistic outlook for investors.
Read full news articleViyash Scientific Ltd Falls 7.76%: 6 Key Factors Driving the Weekly Decline
2026-08-16 13:00:07
Key Events This Week
10 Aug: Stock opens at ₹273.80, down 1.19% on the day
11 Aug: Sharp 4.51% drop amid heavy volume and technical concerns
12 Aug: Positive quarterly financial results announced, stock rebounds slightly
13 Aug: Quality grade upgraded, stock gains 1.33%
14 Aug: Technical momentum shifts bullish, but stock closes lower at ₹255.60

Viyash Scientific Ltd Upgraded to Buy on Strong Financial and Technical Performance
2026-08-14 08:07:03Viyash Scientific Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its financial performance, valuation metrics, quality indicators, and technical trends. The company’s recent quarterly results and sustained growth trajectory have prompted this positive revision, reflecting improved fundamentals and a more attractive risk-reward profile for investors.
Read full news article
Viyash Scientific Ltd Technical Momentum Shifts Signal Bullish Outlook
2026-08-14 08:01:03Viyash Scientific Ltd has demonstrated a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a combination of moving averages, MACD, and Bollinger Bands indicators, suggesting a strengthening price momentum that investors should closely monitor amid the company’s robust year-to-date returns.
Read full news article
Viyash Scientific Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-08-13 08:00:16Viyash Scientific Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change reflects evolving market perceptions amid robust stock performance and improving financial metrics, positioning the small-cap pharmaceutical player as a more attractive option relative to its peers and historical benchmarks.
Read full news articleAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
16-Aug-2026 | Source : BSEEarning call Transcript Q1 FY 2026-27
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
12-Aug-2026 | Source : BSEAudio Recording of Earnings call pertaining to the unaudited Financial Results (Consolidated and Standalone) for the quarter ended June 30 2026
Announcement under Regulation 30 (LODR)-Investor Presentation
12-Aug-2026 | Source : BSEInvestor Presentation Q1 FY 2026-2027
Corporate Actions
No Upcoming Board Meetings
Viyash Scientific Ltd has declared 25% dividend, ex-date: 08 Sep 21
Viyash Scientific Ltd has announced 2:10 stock split, ex-date: 25 Feb 16
No Bonus history available
No Rights history available






